Evonik Industries AG (FRA:EVK)’s share price was down 0.9% during trading on Wednesday . The company traded as low as €23.88 ($27.77) and last traded at €24.55 ($28.55), approximately 2,016,692 shares were traded during mid-day trading. The stock had previously closed at €24.77 ($28.80).
Several brokerages have commented on EVK. UBS Group set a €22.00 ($25.58) target price on shares of Evonik Industries and gave the stock a “sell” rating in a research report on Wednesday, January 22nd. Nord/LB set a €24.00 ($27.91) price target on shares of Evonik Industries and gave the company a “neutral” rating in a report on Tuesday, January 21st. Warburg Research set a €36.00 ($41.86) price objective on shares of Evonik Industries and gave the company a “buy” rating in a research note on Monday, January 6th. Independent Research set a €27.00 ($31.40) price objective on shares of Evonik Industries and gave the stock a “neutral” rating in a report on Wednesday, January 15th. Finally, Kepler Capital Markets set a €23.00 ($26.74) price objective on shares of Evonik Industries and gave the stock a “sell” rating in a report on Tuesday, February 4th. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and eleven have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of €28.65 ($33.32).
The firm has a 50 day moving average price of €25.89 and a 200-day moving average price of €24.84.
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.